Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Aditi Singhai
Alison Sathe
Anders Vinther
Anne-Caroline Boillot
Barbara W. Unger
Barry Price
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Khushboo Agrawal
Mark Agostino
Michael de la Torre
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Tashil Sharma
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Enforcement

FDA Warning Letters Week of 2/23/2020: After 3-Week Absence, 8 to Drug and Device Firms

No items found.
Enforcement

The Importance of Monitoring Import Alerts

No items found.
Conference Spotlight

Part 2: Department of Justice Consumer Protection Branch Doubles in Size to Battle Fraud and Deception in the Drug and Dietary Supplement Industries

No items found.

January 483s: Most Popular and Newsworthy

No items found.
Enforcement

FDA Warning Letters Week of 2/2/2020: Device Repeat Deficiencies

No items found.
Enforcement

FDA Warning Letters Week of 1/26/2020: HCT/P and OTC Products

No items found.

GMP Compliance for Legacy Products: How to Find and Avoid Potential Quality Issues

No items found.

510k – What is the FDA 510(k) Premarket Notification?

No items found.
Enforcement

FDA Warning Letters Week of 1/12/2020: CMO Quality

No items found.

December 483s: Most Popular and Newsworthy

No items found.
Enforcement

Warning Letters Week of 1/5/2020: Data Discrepancies

No items found.
Conference Spotlight

How to Talk So That FDA Will Listen, and How to Listen When They Talk: Advice That Could Be Worth Millions

No items found.

November 483s: Most Popular and Newsworthy

No items found.
Enforcement

FDA Warning Letters Week of 12/15/2019: Independent Assessment Requests

No items found.
Enforcement

FDA Warning Letters Week of 12/8/2019: CAPAs, Complaints, and Quality Systems

No items found.
Enforcement

FDA Warning Letters Week of 12/1/2019: Cell and Tissue Therapies

No items found.
Enforcement

FDA Warning Letters Week of 11/24/2019: Repackaging and CBD Products

No items found.
Enforcement

FDA Warning Letters Week of 11/17/2019: Torrent (Again) and Failing Water Systems

No items found.